Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Meuleman

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Gut|March 24, 2016
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liverIbrahim M Sayed, Lieven Verhoye, Laurence Cocquerel, et al.
Hepatology (Baltimore, Md.)|December 29, 2015
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challengeIsabelle Desombere, Samira Fafi-Kremer, Freya Van Houtte, et al.
Scientific Reports|April 20, 2019
New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycleMaliki Ankavay, Claire Montpellier, Ibrahim M Sayed, et al.
The Journal of Experimental Medicine|August 18, 2010
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantationSamira Fafi-Kremer, Isabel Fofana, Eric Soulier, et al.
Virology|November 13, 2017
Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, et al.
Cell Death & Disease|July 18, 2025
IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte culturesOlga A Khomich, Patrick Giavalisco, Romain Parent, et al.
Hepatology (Baltimore, Md.)|April 23, 2024
JFH1-based Core-NS2 genotype variants of HCV with genetic stability in vivo and in vitro: Important tools in the evaluation of virus neutralizationLaura Collignon, Kenn Holmbeck, Ashley Just, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Experimental Variables that Affect Human Hepatocyte AAV Transduction in Liver Chimeric MiceChenhui Zou, Koen O A Vercauteren, Eleftherios Michailidis, et al.
Journal of Hepatology|March 15, 2012
Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized miceKrzysztof Lacek, Koen Vercauteren, Katarzyna Grzyb, et al.
Frontiers in Immunology|January 3, 2022
A Role for B Cells to Transmit Hepatitis C Virus InfectionIsabelle Desombere, Freya Van Houtte, Ali Farhoudi, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Gut|March 24, 2016
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liverIbrahim M Sayed, Lieven Verhoye, Laurence Cocquerel, et al.
Hepatology (Baltimore, Md.)|December 29, 2015
Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challengeIsabelle Desombere, Samira Fafi-Kremer, Freya Van Houtte, et al.
Scientific Reports|April 20, 2019
New insights into the ORF2 capsid protein, a key player of the hepatitis E virus lifecycleMaliki Ankavay, Claire Montpellier, Ibrahim M Sayed, et al.
The Journal of Experimental Medicine|August 18, 2010
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantationSamira Fafi-Kremer, Isabel Fofana, Eric Soulier, et al.
Virology|November 13, 2017
Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, et al.
Cell Death & Disease|July 18, 2025
IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte culturesOlga A Khomich, Patrick Giavalisco, Romain Parent, et al.
Hepatology (Baltimore, Md.)|April 23, 2024
JFH1-based Core-NS2 genotype variants of HCV with genetic stability in vivo and in vitro: Important tools in the evaluation of virus neutralizationLaura Collignon, Kenn Holmbeck, Ashley Just, et al.
Molecular Therapy. Methods & Clinical Development|July 9, 2020
Experimental Variables that Affect Human Hepatocyte AAV Transduction in Liver Chimeric MiceChenhui Zou, Koen O A Vercauteren, Eleftherios Michailidis, et al.
Journal of Hepatology|March 15, 2012
Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized miceKrzysztof Lacek, Koen Vercauteren, Katarzyna Grzyb, et al.
Frontiers in Immunology|January 3, 2022
A Role for B Cells to Transmit Hepatitis C Virus InfectionIsabelle Desombere, Freya Van Houtte, Ali Farhoudi, et al.
Pageof 13